How To Wow A Study Section: A Grantsmanship Lesson

Morning in Bethesda: The jet-lagged reviewers drag themselves to the hotel conference room for another day of bad coffee and endless grants. The wife of the study section chairman phoned at dawn to announce that she's leaving him for some hotshot postdoc. "Harvard," he reads from your application on top of the stack. "That's where her boyfriend works!" And you can kiss your R01 good-bye. If this is how you picture a study section, you're in for quite a surprise-a more pleasant one than our fic

Written byKaren Hopkin
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

Morning in Bethesda: The jet-lagged reviewers drag themselves to the hotel conference room for another day of bad coffee and endless grants. The wife of the study section chairman phoned at dawn to announce that she's leaving him for some hotshot postdoc. "Harvard," he reads from your application on top of the stack. "That's where her boyfriend works!" And you can kiss your R01 good-bye.

If this is how you picture a study section, you're in for quite a surprise-a more pleasant one than our fictitious chairman received. Study section meetings are actually civil, efficient, and business-like. Although the coffee may be bad, the reviewers are completely professional. And believe it or not, they're on your side.

Ask a successfully funded researcher to critique your grant proposal before you submit it. Be hypothesis-driven, not technique-driven. Clearly state what impact your work will have on a field. Don't be too ambitious; ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies